E
Elisabetta Chiarparin
Researcher at Astex
Publications - 32
Citations - 748
Elisabetta Chiarparin is an academic researcher from Astex. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 16, co-authored 24 publications receiving 641 citations. Previous affiliations of Elisabetta Chiarparin include École Normale Supérieure & University of Lausanne.
Papers
More filters
Journal ArticleDOI
Exploring Weak Ligand–Protein Interactions by Long‐Lived NMR States: Improved Contrast in Fragment‐Based Drug Screening
Roberto Buratto,Daniele Mammoli,Elisabetta Chiarparin,Glyn Williams,Geoffrey Bodenhausen,Geoffrey Bodenhausen +5 more
TL;DR: The use of LLS for competitive binding experiments to measure accurate dissociation constants of fragments that bind weakly to the ATP binding site of the N-terminal ATPase domain of heat shock protein 90 (Hsp90), a therapeutic target for cancer treatment is described.
Journal ArticleDOI
Relaxation of Two-Spin Coherence Due to Cross-Correlated Fluctuations of Dipole−Dipole Couplings and Anisotropic Shifts in NMR of 15N,13C-Labeled Biomolecules
TL;DR: A comprehensive description is presented of the effects on two-spin coherences of cross-correlation between the fluctuations of two different relaxation mechanisms in NMR (NMR) and rates show a high degree of correlation with the backbone Y angles in proteins.
Journal ArticleDOI
Hartmann-Hahn polarization transfer in liquids: An ideal tool for selective experiments
TL;DR: In this article, it has been demonstrated that imperfections in RF-fields have little effect on efficiency of polarization transfer, provided that RF-amplitudes are comparable to magnitudes of heteronuclear scalar coupling constants, rendering this method ideal for selective experiments.
Journal ArticleDOI
Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP)
Emiliano Tamanini,Ildiko Maria Buck,Gianni Chessari,Elisabetta Chiarparin,James Edward Harvey Day,Martyn Frederickson,Charlotte Mary Griffiths-Jones,Keisha Hearn,Tom D. Heightman,Aman Iqbal,Christopher N. Johnson,Edward J. Lewis,Vanessa Martins,Torren M. Peakman,Michael Reader,Sharna J. Rich,George Ward,Pamela A. Williams,Nicola E. Wilsher +18 more
TL;DR: Structural-based drug design guided by structural information from X-ray crystallography, computational studies, and NMR solution conformational analysis was successfully applied to a fragment-derived lead resulting in AT-IAP, a potent, orally bioavailable, dual antagonist of XIAP and cIAP1 and a structurally novel chemical probe for IAP biology.
Journal ArticleDOI
Selective cross-polarization in solution state NMR
TL;DR: In this paper, it is demonstrated by expts and simulations that imperfections in RF fields have little effect on the efficiency of magnetization transfer, provided that the RF amplitudes are comparable with the magnitudes of the heteronuclear scalar coupling.